FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering —

This Safety Announcement from the FDA came out over a year ago yet I read every day about patients being refused refills or quick tapering off of Opioids causing serious withdrawal symptoms. This happened to me at the beginning of the pandemic. I didn’t want to go into the office for a urine sample instead […]

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering —

Please leave a comment what, you have to say is important to us.

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s